These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 416166)

  • 1. Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts.
    Hurme M; Chandler PR; Hetherington CM; Simpson E
    J Exp Med; 1978 Mar; 147(3):768-75. PubMed ID: 416166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-cell responses to H-Y: mapping of the Ir genes.
    Hurme M; Hetherington CM; Chandler PR; Simpson E
    J Exp Med; 1978 Mar; 147(3):758-67. PubMed ID: 416165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of transplant rejection.
    Butcher GW; Howard JC
    Transplantation; 1982 Oct; 34(4):161-6. PubMed ID: 6815843
    [No Abstract]   [Full Text] [Related]  

  • 4. Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.
    Klein J; Geib R; Chiang C; Hauptfeld V
    J Exp Med; 1976 Jun; 143(6):1439-52. PubMed ID: 775014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in histocompatibility immunogenetics.
    Snell GD
    Adv Genet; 1979; 20():291-355. PubMed ID: 117684
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
    Rosenberg AS; Mizuochi T; Singer A
    J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
    Wettstein PJ; Colombo MP; Jaenisch R
    J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-Y status of X/X Sxr' male mice: in vivo tests.
    Simpson E; Chandler P; Hunt R; Hogg H; Tomonari K; McLaren A
    Immunology; 1986 Mar; 57(3):345-9. PubMed ID: 3514439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and agglutinating H-Y antibodies in multiparous female mice.
    Krupen-Brown K; Wachtel SS
    Transplantation; 1979 Jun; 27(6):406-9. PubMed ID: 111380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong histocompatibility and cell-mediated cytotoxic effects of a single Mls difference demonstrated using a new congenic mouse strain.
    Berumen L; Halle-Pannenko O; Festenstein H
    Eur J Immunol; 1983 Apr; 13(4):292-300. PubMed ID: 6221931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
    Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
    Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of graft size on the induction of immunity versus tolerance to H-Y in H-2k strains of mice.
    Ashman RB
    Immunogenetics; 1985; 22(6):585-91. PubMed ID: 3908302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen.
    Gordon RD; Mathieson BJ; Samelson LE; Boyse EA; Simpson E
    J Exp Med; 1976 Sep; 144(3):810-20. PubMed ID: 784891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
    Billings P; Burakoff SJ; Dorf ME; Benacerraf B
    J Exp Med; 1978 Aug; 148(2):341-50. PubMed ID: 100567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-type hypersensitivity responses to H-Y: characterization and mapping of Ir genes.
    Liew FY; Simpson E
    Immunogenetics; 1980; 11(3):255-66. PubMed ID: 6793506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.